INTRODUCTION: The management of recurrent malignant pleural effusions (MPE) can be challenging. Various options are available, with the most efficacious and widely used being talc pleurodesis. Talc can either be applied via a chest drain in the form of slurry, or at medical thoracoscopy using poudrage. Current evidence regarding which method is most effective is conflicting and often methodologically flawed. The TAPPS trial is a suitably powered, multicentre, open-label, randomised controlled trial designed to compare the pleurodesis success rate of medical thoracoscopy and talc poudrage with chest drain insertion and talc slurry. METHODS AND ANALYSIS: 330 patients with a confirmed MPE requiring intervention will be recruited from UK hospit...
BACKGROUND: Malignant pleural effusions (MPEs) remain a common problem, with 40,000 new cases in the...
Talc pleurodesis has been widely used to control malignant pleural effusion; however, it is still no...
Talc pleurodesis has been widely used to control malignant pleural effusion; however, it is still no...
Importance Malignant pleural effusion (MPE) is challenging to manage. Talc pleurodesis is a common a...
Background: There are around 40,000 new cases of malignant pleural effusion in the UK each year. Ins...
INTRODUCTION: Malignant pleural effusion (MPE) is common, with 50 000 new cases per year in the UK. ...
INTRODUCTION: Malignant pleural effusion (MPE) is common, with 50 000 new cases per year in the UK. ...
INTRODUCTION: Malignant pleural effusion (MPE) is common, with 50 000 new cases per year in the UK. ...
INTRODUCTION: Malignant pleural effusion (MPE) is common, with 50 000 new cases per year in the UK. ...
Importance Malignant pleural effusion (MPE) is challenging to manage. Talc pleurodesis is a commo...
Importance Malignant pleural effusion (MPE) is challenging to manage. Talc pleurodesis is a commo...
Objective: The aim of this study was to investigate the effectiveness, safety and appropriate mode o...
Objective: The aim of this study was to investigate the effectiveness, safety and appropriate mode o...
INTRODUCTION: Malignant pleural effusion (MPE) is common, with 50 000 new cases per year in the UK. ...
INTRODUCTION: Malignant pleural effusion (MPE) is common, with 50 000 new cases per year in the UK. ...
BACKGROUND: Malignant pleural effusions (MPEs) remain a common problem, with 40,000 new cases in the...
Talc pleurodesis has been widely used to control malignant pleural effusion; however, it is still no...
Talc pleurodesis has been widely used to control malignant pleural effusion; however, it is still no...
Importance Malignant pleural effusion (MPE) is challenging to manage. Talc pleurodesis is a common a...
Background: There are around 40,000 new cases of malignant pleural effusion in the UK each year. Ins...
INTRODUCTION: Malignant pleural effusion (MPE) is common, with 50 000 new cases per year in the UK. ...
INTRODUCTION: Malignant pleural effusion (MPE) is common, with 50 000 new cases per year in the UK. ...
INTRODUCTION: Malignant pleural effusion (MPE) is common, with 50 000 new cases per year in the UK. ...
INTRODUCTION: Malignant pleural effusion (MPE) is common, with 50 000 new cases per year in the UK. ...
Importance Malignant pleural effusion (MPE) is challenging to manage. Talc pleurodesis is a commo...
Importance Malignant pleural effusion (MPE) is challenging to manage. Talc pleurodesis is a commo...
Objective: The aim of this study was to investigate the effectiveness, safety and appropriate mode o...
Objective: The aim of this study was to investigate the effectiveness, safety and appropriate mode o...
INTRODUCTION: Malignant pleural effusion (MPE) is common, with 50 000 new cases per year in the UK. ...
INTRODUCTION: Malignant pleural effusion (MPE) is common, with 50 000 new cases per year in the UK. ...
BACKGROUND: Malignant pleural effusions (MPEs) remain a common problem, with 40,000 new cases in the...
Talc pleurodesis has been widely used to control malignant pleural effusion; however, it is still no...
Talc pleurodesis has been widely used to control malignant pleural effusion; however, it is still no...